Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00907309 · ClinicalTrials.gov registry record · Phase 1

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

A Phase 1 study of Alcohol Abuse and Drug Abuse, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 1
Development phase
121
Enrollment target
1
Study location

NCT00907309 is a Phase 1 study of Alcohol Abuse and Drug Abuse that has completed, run by Boston Children's Hospital. The registered enrollment target is 121 participants, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00907309, a Phase 1 study of Alcohol Abuse and Drug Abuse, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 1
Development phase
121 participants
Enrollment target
1
Study location

Study Summary

The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

Interventions

  • BEHAVIORAL iMET
  • BEHAVIORAL iMET/TE

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2010-09
Est. Completion 2012-09
Phase Phase 1

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00907309

The ClinicalTrials.gov registry entry for NCT00907309 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (83% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which iMET is the first listed.

NCT00907309 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00907309 about?

NCT00907309 is a clinical study titled "Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use". The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

What is the current status of trial NCT00907309?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 121 participants. The study started on 2010-09. Estimated completion is 2012-09.

What conditions does trial NCT00907309 study?

This clinical trial studies the following conditions: Alcohol Abuse, Drug Abuse, Use; Tobacco, Harmful.

What interventions are being tested in trial NCT00907309?

The interventions under investigation include: iMET (BEHAVIORAL), iMET/TE (BEHAVIORAL).

Who is sponsoring clinical trial NCT00907309?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00907309 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.